Table 4.

Description of the whole dataset for the mycotoxins analysed in urine samples.

Group	Observations	% Positive	Mean (ng/mL)	SD (ng/mL)	Min–Max (ng/mL)	Median (ng/mL)
Whole Group	163/233 *
GLIO		71.6%	8.2	1.5	0–114.7	3.9
OTA		74.8%	0.09	0.09	0–0.54	0.08
AFB1		66.2%	0.01	0.01	0–0.06	0.02
AFM1		62.6%	0.12	0.12	0–0.70	0.15
ZEA		51.0%	0.7	1.1	0–6.5	0.8
DON		38.6%	0.7	1.1	0–4.6	0.0
DOM1		27.0%	2.1	4.2	0–19.5	0.0
FB1		44.5%	0.4	1.1	0–12.4	0.0
Autistic Group	114
GLIO		69.2%	7.6	13.6	0–82.7	3.5
OTA		70.2%	0.09	0.10	0–0.54	0.08
AFB1		63.2%	0.01	0.01	0–0.06	0.02
AFM1		60.7%	0.12	0.13	0–0.70	0.15
ZEA		50.5%	0.8	1.2	0–6.5	0.8
DON		46.5%	0.9	1.2	0–4.6	0.0
DOM1		32.4%	2.5	4.5	0–19.5	0.0
FB1		43.9%	0.5	1.3	0–12.4	0.0
Siblings	25
GLIO		80.0%	11.6	24.7	0–114.7	5.3
OTA		84.0%	0.09	0.07	0–0.27	0.08
AFB1		80.0%	0.01	0.01	0–0.03	0.02
AFM1		84.0%	0.16	0.11	0–0.43	0.15
ZEA		48.0%	0.5	0.7	0–2.8	0.0
DON		16.0%	0.4	1.0	0–3.7	0.0
DOM1		8.0%	0.8	2.8	0–12.0	0.0
FB1		56.0%	0.4	0.5	0–2.0	0.5
Non-Parental	24
GLIO		77.3%	7.7	9.8	0–39.7	4.2
OTA		87.5%	0.09	0.05	0–0.19	0.08
AFB1		66.7%	0.01	0.01	0–0.02	0.02
AFM1		54.2%	0.08	0.09	0–0.25	0.15
ZEA		59.1%	0.6	0.8	0–3.17	0.78
DON		25.0%	0.4	0.8	0–2.3	0.0
DOM1		22.7%	1.8	3.6	0–11.4	0.0
FB1		36.4%	0.2	0.4	0–1.5	0.0

* Due to the low amount of samples collected from some children, it was not always possible to carry out all the analyses planned for the study.